SCHEMBL31708137

SCHEMBL31708137

CCNC(=O)C(=O)c1c[nH]c2c(Br)cc(Cl)c(OC)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 3/20 0.36
▸ MTNR1B P49286 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ GABRP O00591 6/20 0.36
▸ GABRD O14764 6/20 0.36
▸ GABRA1 P14867 6/20 0.36
▸ GABRB1 P18505 6/20 0.36
▸ GABRG2 P18507 6/20 0.36
▸ GABRB3 P28472 6/20 0.36
▸ GABRA5 P31644 6/20 0.36
▸ GABRA3 P34903 6/20 0.36
▸ GABRA2 P47869 6/20 0.36
▸ GABRB2 P47870 6/20 0.36
▸ GABRA4 P48169 6/20 0.36
▸ GABRE P78334 6/20 0.36
▸ GABRA6 Q16445 6/20 0.36
▸ GABRG1 Q8N1C3 6/20 0.36
▸ GABRG3 Q99928 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31708112 0.78 GABRP (0.42) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30712094 0.74 BRD4 (0.42) GAAGABRPGABRDGABRA1GABRB1
SCHEMBL30712065 0.66 KMT2A (0.39) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30712082 0.65 MTNR1A (0.53) MTNR1AMTNR1BGABRPGABRDGABRA1
SCHEMBL30712083 0.65 MTNR1A (0.53) MTNR1AMTNR1BGABRPGABRDGABRA1
SCHEMBL12596320 0.65 CCNB2 (0.39) MTNR1AMTNR1BALDH1A1SMN1; SMN2
SCHEMBL19426014 0.62 HTT (0.42) KDM4EALDH1A1GABRPGABRDGABRA1
SCHEMBL1163916 0.61 LMNA (0.40) KDM4EALDH1A1GAAHTTMAPT
SCHEMBL31708181 0.60 ALOX5 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12215131 0.60 CNR1 (0.40) KDM4EALDH1A1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback